Site-specific antibody-polymer conjugates for siRNA delivery. - Wikidata - wikimedia - TriplyDB

Site-specific antibody-polymer conjugates for siRNA delivery.

Site-specific antibody-polymer conjugates for siRNA delivery.

http://www.wikidata.org/entity/Q37638814

about

Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy.Bioconjugation of therapeutic proteins and enzymes using the expanded set of genetically encoded amino acids.At the Interface of Chemical and Biological Synthesis: An Expanded Genetic Code.A DNA dual lock-and-key strategy for cell-subtype-specific siRNA delivery.EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.Nucleic Acid Bioconjugates in Cancer Detection and Therapy.A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growth in vivo.Therapeutic applications of an expanded genetic code.Unnatural amino acids in novel antibody conjugates.Biological applications of expanded genetic codes.Bioengineering strategies to generate artificial protein complexes.Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.Bioconjugation - using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers.Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates.In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures Cyclen-based cationic lipids containing a pH-sensitive moiety as gene delivery vectors."Bio"-macromolecules: polymer-protein conjugates as emerging scaffolds for therapeutics.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Three-Dimensional Ordered Antibody Arrays Through Self-Assembly of Antibody-Polymer Conjugates.Playing with the molecules of life.A Switchable Site-Specific Antibody Conjugate.Site-Specific Antibody Conjugation for ADC and Beyond.

P2860

Q27339704-436F086C-D414-4FDB-A272-71B30FBA0541 Q30275229-9C7E1B6F-B771-4ADB-ADF3-141653A00596 Q30279245-F365A2CF-EC5E-496F-8448-18A1FC23AB12 Q30390524-45D77917-1BAB-4E6D-91C9-06EA4481F399 Q33813408-12635F62-6F9B-41FA-B6BF-44E431ACF30C Q35018628-48DD4A21-FECB-483D-B9E4-EC5999B6880D Q35867875-C94195B1-04F5-4141-B633-F5BE83D019BC Q37013316-1D20AB29-2A5F-46E5-B70F-08C50F350DD8 Q38232022-F22C0240-9E54-4A51-A5C9-69A332869385 Q38243891-9EAD78AB-87C9-4F7E-A9EC-9C707F04FB73 Q38244615-C8514513-F079-48AF-B649-8EC2F8D04AC3 Q38460874-5BDE1624-4FEB-4692-A43F-094647385D23 Q38876382-181FACB4-30E9-4548-9665-22668A3363AF Q38909537-A14224BB-4F9A-4AD9-836E-FF659756896F Q38924311-A1601562-F7DC-4267-BA13-22C3365CD4BC Q41502965-20845C25-1652-47DA-8EF6-289780ED29B3 Q42182139-585B5E72-7D55-4E81-AB1D-4CD578F81674 Q46335892-920759A3-A970-433F-A504-3F9EBBDABF76 Q47152520-94DEDE4B-0FC9-4451-9BFD-72EC951DB0E5 Q48112568-789DFEA5-116D-47AE-A097-8E543C208631 Q49968034-F9787E46-312E-4AF3-95F7-A7D1621A85A6 Q50027030-262305E2-3A27-4E1A-95BC-63C300638CA2 Q55022669-26F9C1C7-7EF6-44B6-86E9-B4D068AB09B2

P2860

Site-specific antibody-polymer conjugates for siRNA delivery.

http://www.wikidata.org/entity/Q37638814

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Site-specific antibody-polymer conjugates for siRNA delivery.

@en

Site-specific antibody-polymer conjugates for siRNA delivery.

@nl

type

label

Site-specific antibody-polymer conjugates for siRNA delivery.

@en

Site-specific antibody-polymer conjugates for siRNA delivery.

@nl

prefLabel

Site-specific antibody-polymer conjugates for siRNA delivery.

@en

Site-specific antibody-polymer conjugates for siRNA delivery.

@nl

P1433

Q37638814-38772DCA-A0BA-4570-9AE0-5587EAEB686B

P1476

Q37638814-5F1DF2D6-80CF-4B30-8BA0-928C0D756F4B

P2093

Q37638814-026BD7C7-16F7-4BD4-8636-39DA5F8738DD

Q37638814-342DA89A-8621-4F8D-8F97-ABE06F455DD1

Q37638814-49F42C0E-E837-4432-885C-C3EA865CE98C

Q37638814-5F3D91AA-F6D0-47B8-9E08-BB3B8B508E45

Q37638814-9FE44C9D-6762-4837-BAFF-2A9BDB8CA639

Q37638814-CA842314-BF70-45EF-9A77-5B0371F47093

Q37638814-D5F65643-910E-4B57-BC83-AEF5D834EC10

Q37638814-EA65A9BF-3231-42FA-A4A4-6729E56B637D

Q37638814-FF64B49D-1261-43AB-8415-219ED8A687DA

P2860

Q37638814-07A1C76B-48AC-4ACD-BC0C-2AB57AEA78C8

Q37638814-0A017FA5-140B-48F3-A595-F632939FF1DF

Q37638814-0D6804F9-1E8D-4DB9-9FBF-0C078A5FAAB6

Q37638814-0D7B743A-4EBE-44F0-AF31-75BCB391C57B

Q37638814-0DE4216C-0FBC-4BA9-93BC-8B1D0A2F3B52

Q37638814-13CAD10C-D5B5-4F07-AB76-9240CB9657B8

Q37638814-14C6D68E-5EF1-4659-9EC1-04FD32AA7D9D

Q37638814-18750FBE-608C-4700-9712-67F29CAA5201

Q37638814-1C3BB979-4DCB-43F1-B282-5805B8F438EE

Q37638814-29066DCE-567B-4F75-91AC-EC1568D4C36C

P304

Q37638814-040DBFB4-1FE1-4156-A83B-774EC24C14E4

P31

Q37638814-7FF58461-4585-4AC1-A79D-F46F7BEB33E8

P356

Q37638814-37EEFEA0-3642-4F2C-BB9A-D36AAA648606

P407

Q37638814-4BB4253A-34FA-47F8-992C-780714176F54

P433

Q37638814-4B16F5E3-3DE4-459B-9B0E-0D7BCC6D7444

P478

Q37638814-FF8AE965-A509-4C14-A73D-6EB506CC9DA2

P577

Q37638814-263908E6-A38A-4247-A693-7521DEB91FA0

P698

Q37638814-5F4878F9-F067-4356-9FA9-6EFA182DE35B

P921

Q37638814-BD0BF14B-9DDE-4BC6-8D3F-D5F810A7A2B3

P932

Q37638814-4384E268-76BB-4ED0-8BF8-A503AAAD46B2

P356

P1433

Journal of the American Chemical Society

P1476

Site-specific antibody-polymer conjugates for siRNA delivery.

@en

P2093

Aaron Sellers

http://www.w3.org/2001/XMLSchema#string

Barney Barnett

http://www.w3.org/2001/XMLSchema#string

Danling Wang

http://www.w3.org/2001/XMLSchema#string

Feng Tian

http://www.w3.org/2001/XMLSchema#string

Frank Song

http://www.w3.org/2001/XMLSchema#string

Hua Lu

http://www.w3.org/2001/XMLSchema#string

Peter G Schultz

http://www.w3.org/2001/XMLSchema#string

Stephanie Kazane

http://www.w3.org/2001/XMLSchema#string

Tsotne Javahishvili

http://www.w3.org/2001/XMLSchema#string

P2860

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

Expanding the genetic code of Escherichia coli

Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

Silencing disease genes in the laboratory and the clinic

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Addition of the keto functional group to the genetic code of Escherichia coli.

Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA).

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

P304

13885-13891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA4059525

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23924037

http://www.w3.org/2001/XMLSchema#string

P921

P932

3955097

http://www.w3.org/2001/XMLSchema#string